基乙胺和胺类类似物修复GNE功能障碍导致的缺陷:罕见疾病治疗意义
Shagun Singh1, Meenakshi Bansal2, Neha Sharma2
1School of Biotechnology, Jawaharlal Nehru University, New Delhi, 110067, India.
Molecular medicine (Cambridge, Mass.)
|December 3, 2025
概括
新型氧乙胺和胺类类似物 (LTC-181,LTC-1717) 对GNE肌病有前途. 这些化合物恢复了细胞模型中的GNE表皮酶活性和酸水平,改善了细胞活力并减少了肌肉缩.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 罕见疾病 罕见疾病
背景情况:
- 基因基因肌病是一种罕见的,使人衰弱的神经肌肉疾病,由基因基因突变引起.
- GNE基因编码了酸生物合成中的关键酶,其活性减少导致疾病病理.
- 目前对GNE肌肉病的治疗选择有限,这凸显了对新型治疗策略的需求.
研究的目的:
- 评估两种新型基乙烯胺和胺类类似物LTC-181和LTC-1717的治疗潜力.
- 为了研究这些化合物对突变GNE蛋白的表皮酶活性和酸生产的影响.
- 评估这些类似物对关联于GNE肌性病的细胞功能的影响,包括细胞活力,细胞骨组织和自.
主要方法:
- 在体外测试测量突变GNE蛋白的表皮酶活性 (r-F307C-GNE和r-A555V-GNE).
- 利用基于肌肉细胞的模型 (SKM-GNEHz) 来评估化合物对GNE功能,酸含量和细胞活性的影响.
- 蛋白质组分析用于研究细胞通路中化合物介导的变化.
- 分子对接和相互作用研究,以比较LTC-1717和LTC-181与GNE的结合潜力.
主要成果:
- LTC-181和LTC-1717显著增强了突变GNE蛋白的体外表皮酶活性.
- 用这些类似物治疗在SKM-GNEHz细胞模型中增加了GNE表皮酶活性和酸含量两倍.
- 蛋白质组学研究表明,这些化合物调节了细胞骨组织,自和肌肉缩途径.
- 化合物改善了细胞活力,F-actin聚合和GNE缺乏细胞中的细胞迁移,恢复正常的细胞功能.
结论:
- 基乙胺和胺类类似物 (LTC-181,LTC-1717) 显示出对GNE肌病的显著治疗潜力.
- 与LTC-181相比,LTC-1717对GNE蛋白具有更高的稳定性,这表明治疗效率提高.
- 这些发现为开发针对GNE肌肉病的新型治疗提供了坚实的基础.
更多相关视频
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
9.0K
09:45Modification and Functionalization of the Guanidine Group by Tailor-made Precursors
Published on: April 27, 2017
11.1K
相关概念视频
Preparation of 1° Amines: Gabriel Synthesis
4.5K
Direct alkylation is not a suitable method for synthesizing amines because it produces polyalkylated products. Gabriel synthesis is the most preferred method to exclusively make primary amines. The method uses phthalimide, which contains a protected form of nitrogen that participates in alkylation only once to predominantly give primary amines.
Strong bases like NaOH or KOH deprotonate the phthalimide to form the corresponding anion, which acts as a nucleophile. Further, the anion attacks an...
Strong bases like NaOH or KOH deprotonate the phthalimide to form the corresponding anion, which acts as a nucleophile. Further, the anion attacks an...
4.5K
Transducer Mechanism: Enzyme-Linked Receptors
3.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.8K
